MIRA INFORM REPORT

 

 

Report Date :

30.06.2012

 

IDENTIFICATION DETAILS

 

Name :

SAHAJANAND MEDICAL TECHNOLOGIES PRIVATE LIMITED

 

 

Registered Office :

Sahajanand Estate, Wakharia Wadi, Nr. Dabholi Char Rasta, Nani Ved, Ved Road, Surat 395004, Gujarat

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

18.10.2001

 

 

Com. Reg. No.:

04- 040121

 

 

Capital Investment/ Paid-up Capital:

Rs.49.384 Millions

 

 

 

CIN No.:

[Company Identification No.]

U33119GJ2001PTC040121

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

SRTS00849C

 

 

PAN No.:

[Permanent Account No.]

AALFS5210P

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Developer and Manufacturer of minimally invasive coronary stent systems, with one of the broadest product portfolio in the industry.

 

 

No. of Employees:

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (45)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 1083000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track. There appears some dip in the turnover as well as in the profitability of the company. However, trade relations are reported to be fair. Business is active. Payments are reported to be usually correct and as per commitment.

 

The company can be considered for normal business dealings at usual trade terms and conditions 

 

 

NOTES:

 

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – September 30, 2011

 

Country Name

Previous Rating

(30.06.2011)

Current Rating

(30.09.2011)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

LOCATIONS

 

Registered Office :

Sahajanand Estate, Wakharia Wadi, Nr. Dabholi Char Rasta, Nani Ved, Ved Road, Surat 395004, Gujarat, India

Tel. No.:

91-261-3060606

Fax No.:

91-261-3060607

E-Mail :

dlalkotadia@sahmed.com

Web Site:

www.smtpl.com/

 

 

Head Office:

Head Office, Sahajanand House, Parsi Street, Saitedpura, Surat Gujarat, India

 

 

DIRECTORS

 

AS ON 30.09.2011

 

Name :

Mr. Dhirajlal Vallabhbhai Kotadia

Designation :

Director

Address :

43, Narayanmuni Nagar, Near Swaminarayan Gurukul, Ved Road, Surat – 395 004, Gujarat, India

Date of Birth/Age :

01.01.1958

Qualification :

B.E.

Date of Appointment :

25.03.2004

Din No.:

00013035

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U36912GJ1999PTC035792

SAHAJANAND VASCULAR TECHNOVENTIONS PRIVATE LIMITED

Director

16/04/1999

16/04/1999

-

Strike off

NO

2

U24231GJ2001PTC039726

SAHAJANAND LIFE SCIENCES PRIVATE LIMITED.

Director

2/7/2001

2/7/2001

-

Active

NO

3

U85110GJ2000PLC037625

SAHAJANAND HEALTHCARE LIMITED

Director

24/01/2003

24/01/2003

-

Strike off

NO

4

U33119GJ2001PTC040121

SAHAJANAND MEDICAL TECHNOLOGIES PRIVATE LIMITED

Director

25/03/2004

25/03/2004

-

Active

NO

5

U65910GJ1992PTC017573

NYALKARAN INDUSTRIES PRIVATE LIMITED

Director

25/03/2004

25/03/2004

-

Active

NO

6

U72900GJ1993PTC019133

SAHAJANAND TECHNOLOGIES PRIVATE LIMITED

Director

25/03/2004

25/03/2004

-

Active

NO

7

U33120GJ2010PTC063150

ANGIOMETRIX MEDEQUIPS INDIA PRIVATE LIMITED

Director

6/12/2010

6/12/2010

-

Active

NO

8

U85110GJ2011PTC067523

SUAYU HEALTH RESORTS PRIVATE LIMITED

Director

18/10/2011

18/10/2011

-

Active

NO

 

 

Name :

Mr. Dhirajkumar Savjibhai Vasoya

Designation :

Director

Address :

12-13, Raghuveer Society, Near Govindji Park, Opposite S.V.R. Engineering College, Piplod, Surat – 395017, Gujarat, India

Date of Birth/Age :

03.04.1962

Date of Appointment :

12.05.2006

Din No.:

00013067

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U36912GJ1999PTC035792

SAHAJANAND VASCULAR TECHNOVENTIONS PRIVATE LIMITED

Director

31/05/1999

31/05/1999

-

Strike off

NO

2

U24231GJ2001PTC039726

SAHAJANAND LIFE SCIENCES PRIVATE LIMITED.

Director

19/08/2002

19/08/2002

-

Active

NO

3

U85110GJ2000PLC037625

SAHAJANAND HEALTHCARE LIMITED

Director

24/01/2003

24/01/2003

-

Strike off

NO

4

U33119GJ2001PTC040121

SAHAJANAND MEDICAL TECHNOLOGIES PRIVATE LIMITED

Director

12/5/2006

12/5/2006

-

Active

NO

5

U36939GJ1998PTC034244

SAHAJANAND DIAMONDS PRIVATE LIMITED

Director

12/5/2006

12/5/2006

-

Strike off

NO

6

U65910GJ1992PTC017573

NYALKARAN INDUSTRIES PRIVATE LIMITED

Director

12/5/2006

12/5/2006

-

Active

NO

7

U72900GJ1993PTC019133

SAHAJANAND TECHNOLOGIES PRIVATE LIMITED

Managing director

1/10/2008

12/5/2006

-

Active

NO

8

U29199GJ1997PTC032545

SHIV LASER TECH PRIVATE LIMITED

Director

10/9/2009

10/9/2009

-

Strike off

NO

9

U33120GJ2010PTC063150

ANGIOMETRIX MEDEQUIPS INDIA PRIVATE LIMITED

Director

6/12/2010

6/12/2010

-

Active

NO

10

U85110GJ2011PTC067523

SUAYU HEALTH RESORTS PRIVATE LIMITED

Director

18/10/2011

18/10/2011

-

Active

NO

 

 

Name :

Mr. Jayantilal Kanubhai Vaghasia

Designation :

Director

Address :

102, Saujanya Apartment, City Light Road, Parle Point, Surat – 395007, Gujarat, India

Date of Birth/Age :

15.04.1974

Date of Appointment :

02.08.2003

Din No.:

00035694

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U33119GJ2001PTC040121

SAHAJANAND MEDICAL TECHNOLOGIES PRIVATE LIMITED

Director

2/8/2003

2/8/2003

-

Active

NO

2

U24231GJ2001PTC039726

SAHAJANAND LIFE SCIENCES PRIVATE LIMITED.

Director

23/09/2010

19/11/2009

-

Active

NO

3

U72900GJ1993PTC019133

SAHAJANAND TECHNOLOGIES PRIVATE LIMITED

Additional director

1/3/2012

1/3/2012

-

Active

NO

4

AAA-1274

ZEUS DATA POWER LLP

-

3/5/2010

3/5/2010

-

Active

NO

5

AAA-1274

ZEUS DATA POWER LLP

-

3/5/2010

3/5/2010

-

Active

NO

 

 

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

 

As on 30.09.2011

 

Names of Shareholders

 

No. of Shares

Sharada D. Kotadia

 

3750000

Dhirajlal V. Kotadia

 

38943800

Dhirajkumar S. Vasoya

 

2135000

Vinodkumar S. Vasoya

 

2093700

Jitendra Kotadia

 

70000

Naynaben Vasoya

 

336000

Debadiprasad Roy

 

14000

Rahul Gaywala

 

56000

Hitesh Vachchani

 

70000

Vallabhbhai Narola

 

28000

Manish Patel

 

70000

Sahajanand Technologies Private Limited, India

 

810300

Vasantben Vasoya

 

336000

 

 

AS ON 30.09.2011

 

Category

 

Percentage

 

 

 

Foreign holdings [Foreign institutional investors, Foreign Companies, Foreign Financial Institutions, Non-resident Indian or Overseas corporate bodies or others]

 

0.10

Bodies corporate

 

1.54

Directors or relatives of directors

 

96.72

Other top fifty shareholders

 

0.12

Others

 

1.52

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Developer and Manufacturer of minimally invasive coronary stent systems, with one of the broadest product portfolio in the industry.

 

 

 

 

PRODUCTION STATUS as on 31.03.2011

 

 

31.03.2011

 

Bare Stent (Installed Capacity ) (As Certified By Management)

 

30000 No.s

Actual Production

20530 No.s

Installed Capacity Crimped Stent (As Certified By Management)

25500 No.s

Actual Production Crimped Stent

3765 No.s

 

 

Particulars

Unit

Licensed Capacity

Installed Capacity

Actual Production

Bare Stent

No.s

 

30000

20530

Crimped Stent

No.s

 

25500

3865

 

Note: the items manufacturer by the company are not covered by any license and not hence license capacity in not applicable  in the products manufacturer by the company

 

GENERAL INFORMATION

 

 

No. of Employees :

Not Available

 

 

Bankers :

·         ICICI Bank Limited, Landmark Race Cource Circle, Alkapuri, Baroda – 390 015, Gujarat, India

·         HDFC Bank

·         Kotak Mahindra Bank

·         Punjab National Bank

 

 

Facilities :

Rs. In Millions

SECURED LOAN

31.03.2011

31.03.2010

From Punjab National Bank

 

 

Cash Credit Facility

109.412

34.298

Export packing Credit Facility

8.219

19.906

From ICICI Bank Limited

 

 

Term Loan

2.370

9.871

Vehicle Loan

0.000

0.570

From HDFC Bank Limited

 

 

Vehicle Loan

0.493

1.059

From Kotak Mahindra Prime Limited

 

 

Vehicle Loan

0.247

0.452

Total

120.741

66.156

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Surendra Shah and Associates

Chartered Accountants

Address :

7006, 7th Floor, World Trade Centre, Near Udhna Darwaja, Ring Road, Surat – 395 002, Gujarat, India

Tel. No.:

91-261-2353774 / 2302346 / 3912346 / 6662346

Fax No.:

91-261-2334427

E-Mail :

rajeshshah_surat@hotmail.com

Pan No.:

ACIPS3187Q

 

 

Group Company   :

Sahajanand Technologies (Private) Limited

Sahajanand Life Sciences (Private) Limited

 

 

Subsidiaries :

SMT Vasuler Hk Limited,  Hong Kong

 

 

CAPITAL STRUCTURE

As on 31.03.2011

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

100000000

Equity Share

Rs.10/- each

Rs.100.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

49383700

Equity Share

Rs.10/- each

Rs.49.383 Millions

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

49.384

49.384

49.175

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

221.331

197.455

115.933

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

270.715

246.839

165.108

LOAN FUNDS

 

 

 

1] Secured Loans

120.741

66.156

129.447

2] Unsecured Loans

0.000

0.000

6.400

TOTAL BORROWING

120.741

66.156

135.847

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

391.456

312.995

300.955

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

82.490

81.626

74.182

Capital work-in-progress

64.052

1.945

23.263

 

 

 

 

INVESTMENT

0.079

0.000

0.000

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

66.475
43.267
52.414

 

Sundry Debtors

163.359
131.388
176.414

 

Cash & Bank Balances

4.073
30.847
1.404

 

Other Current Assets

3.536
90.532
73.993

 

Loans & Advances

87.224
3.058
0.918

Total Current Assets

324.667

299.092

305.143

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditor

26.449
15.410

42.923

 

Other Current Liabilities

49.301
36.841
50.127

 

Provisions

7.606
17.427
8.762

Total Current Liabilities

83.356

69.678

101.812

Net Current Assets

241.311

229.414

203.331

 

 

 

 

MISCELLANEOUS EXPENSES

3.524

0.010

0.179

 

 

 

 

TOTAL

391.456

312.995

300.955

 


 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2011

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

Income

328.899

421.262

351.136

 

 

Other Income

1.343

1.999

 1.518

 

 

TOTAL                                     (A)

330.242

423.261

352.654

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

TOTAL                                     (B)

267.669

288.915

330.480

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

62.573

134.346

22.174

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

9.732

10.403

19.542

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

52.841

123.943

2.632

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

23.022

26.814

28.675

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

29.819

97.129

(26.043)

 

 

 

 

 

Less

TAX                                                                  (H)

5.943

16.508

6.000

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

23.876

80.621

(32.043)

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

23.876

80.621

(32.043)

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

98.41

152.530

146.367

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

FOB value

82.287

76.355

80.721

 

 

Custom Duty

9.268

6.741

9.011

 

 

Freight, Insurance and Clearing forwarding Expenses

2.024

2.163

2.015

 

TOTAL IMPORTS

93.579

85.259

91.747

 

 

 

 

 

 

Earnings Per Share (Rs.)

0.48

1.63

(0.66)

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

PAT / Total Income

(%)

7.23

19.04

(9.09)

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

9.07

23.06

(7.41)

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

7.32
25.51
(6.87)

 

 

 
 
 

Return on Investment (ROI)

(PBT/Networth)

 

0.11
0.39
(0.16)

 

 

 
 
 

Debt Equity Ratio

(Total Liability/Networth)

 

0.75
0.55
1.44

 

 

 
 
 

Current Ratio

(Current Asset/Current Liability)

 

3.89
4.29
3.00

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

Check List by Info Agents

Available in Report [Yes/No]

Year of Establishment

Yes

Locality of the Firm

Yes

Constitution of the firm

Yes

Premises details

No

Type of Business

Yes

Line of Business

Yes

Promoters background

Yes

No. of Employees

No

Name of Person Contacted

No

Designation of contact person

No

Turnover of firm for last three years

Yes

Profitability for last three years

Yes

Reasons for variation <> 20%

-

Estimation for coming financial year

No

Capital the business

Yes

Details of sister concerns

Yes

Major Suppliers

No

Major Customers

No

Payment Terms

No

Export / Import Details [If Applicable]

No

Market Information

-

Litigations that the firm / promoter involved in

-

Banking Details

Yes

Banking Facility Details

Yes

Conduct of the banking account

-

Buyer visit details

-

Financials, if provided

Yes

Incorporation details, if applicable

Yes

Last accounts filed at ROC

Yes

Major Shareholders, if applicable

Yes

 

 

Note: The Registered office of the company has been shifted from 304 Sahajanand House  Parsistreet

Saiyedpura Surat Gujarat - 395003 India to the present address w.e.f. 29.04.2011

 

PERFORMANCE OF THE COMPANY:

 

During the year sales revenue from operations decreased by 22% to Rs.326.670 Millions from Rs.421.300 Millions in previous accounting period. The operating profit of the company has decreased to Rs.62.600 Million from 134.300 Millions in the previous accounting period profit after tax ahs decreased to Rs.23.900 Millions to Rs 60.600 Millions in the previous accounting period

 

A change in product mix emphasizing more on high margin products as well as higher inclination towards export has provided a substantial upward thrust in the performance and prospects of the company 

 

A change in product mix emphasizing more on high margin products has provided a substantial upward thrust and the managements have tried their best to turn this as profitable year of the company

 

During the year they have progress well to build the manufacturing facility  at surat, SEZ sachin to help to hep support the increasing demand for their products, they are confident to start manufacturing in the new facility by mid of November 2011

 

The biggest achievement is the CE approval fro Supralimus and Supralimus core, with the CE approval they are confident to increase the export revenue by manifold

 

BUSINESS

 

The coronary stent industry witnessed double digit growth in India Although a Challenging year they have not let effect their market share in India. They are now focusing on selling more DES and our DES to BMS ration in sale has dramatic improvement in the concluding financial year they are confident to further enhance their market share DES market   

 

FROM 8:

 

Corporate identity number of the company

U33119GJ2001PTC040121

Name of the company

SAHAJANAND MEDICAL TECHNOLOGIES PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

Sahajanand Estate, Wakharia Wadi, Nr. Dabholi Char Rasta, Nani Ved, Ved Road, Surat 395004, Gujarat, India

Email: dlalkotadia@sahmed.com

This form is for

Creation of charge

Type of charge

·         Book Debt

·         Movable Property

Particular of charge holder

Bank of Baroda, Sayedpura Branch, Syeadpura, Surat – 395003, Gujarat, India

Email: sayedp@bankofbaroda.com

Nature of instrument creating charge

Hypothecation Agreement

Date of instrument Creating the charge

04.05.2011

Amount secured by the charge

Rs.150.000 Millions

Brief of the principal terms an conditions and extent and operation of the charge

Rate of interest

1. Cash Credit - 14.50% p.a. at present at monthly rests.

2. PC/PCFC cum FBP/FCBP/FBD/FCBD- 10.50% p.a. at present at monthly rests.

 

Terms of repayment

Cash Credit, hence not applicable but repayable on demand.

Margin

1. Cash Credit- 25% for RM, SIP, FG, Stores & Spares and Packing materials 40% for Book debts upto 90 days.

2. PC/PCFC cum FBP/FCBP/FBD/FCBD- 25% on FOB value of export order. NIL on foreign bills to be purchased/discounted.

3. Inland/Foreign Letter of Credit (DP) cum Letter of comfort - DP L/C: 25% Cash Margin at the time of establishing L/C.

Extent and Operation of the charge:

This charge will be for Rs.150.000 Millions against the hypothecation of the inventory, book debts and movable assets of the company

 

FIXED ASSETS

 

·         Building

·         Plant and Machinery

·         Office Equipments

·         Computers

·         Furniture and Fixtures

·         Vehicles

·         Leasehold Improvements

·         Patent

·         Computer Software

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.56.53

UK Pound

1

Rs.88.09

Euro

1

Rs.70.83

 

 

INFORMATION DETAILS

 

 

Report Prepared by :

BYI

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

45

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.